* FDA grants Roche label extension for cobas egfr mutation
test v2 for use with plasma as a companion diagnostic for
Tagrisso
The post BRIEF-FDA grants Roche label extension for cobas EGFR mutation test appeared first on NASDAQ.
BRIEF-FDA grants Roche label extension for cobas EGFR mutation test
